相关实验视频

Updated: Jun 18, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

了解多种癌症检测测试的情况:当前的数据和临床考虑

Cody E Cotner^1,2, Elizabeth O'Donnell^1,2,3

¹Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

Life (Basel, Switzerland)

|July 27, 2024

概括

多种癌症检测 (MCD) 血液检测对早期癌症检测有希望. 本综述考察了领先的MCD平台,CancerSEEK和Galleri,以及它们对更广泛使用的临床考虑.

科学领域:

在瘤学瘤学.
生物标志物生物标志物
诊断技术诊断技术的使用

背景情况:

多种癌症检测 (MCD) 测试是基于血液的测试,旨在同时查多种癌症.
这些测试代表了早期癌症检测的重大进步,旨在提高查的普及率.
目前,没有MCD测试是FDA批准的,尽管有一个商业可用.

研究的目的:

审查两个领先的多重疾病平台的表现:CancerSEEK和Galleri.
讨论MCD技术更广泛应用的临床考虑.
为癌症查中MCD测试的当前环境提供概述.

主要方法:

评估MCD测试的前性干预研究的审查.
对CancerSEEK和Galleri平台的性能数据的分析.
讨论MCD测试的临床实用性和实施挑战.

主要成果:

已经进行了两项前性干预研究,以评估MCD测试作为查工具.
目前正在进行的临床试验正在评估MCD测试的有效性,安全性和成本效益.
该审查侧重于CancerSEEK和Galleri的特定性能特征.

结论:

MCD测试为改善早期癌症检测率提供了一个有希望的途径.
需要进行进一步的研究和临床试验,以确定MCD测试的全部有效性,安全性和成本影响.
临床考虑对于将MCD技术成功整合到常规癌症查方案中至关重要.

关键词:

癌症寻找寻找癌症画廊中的画廊.癌症查癌症查检测多种癌症的测试.

更多相关视频

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...